Tyra Biosciences price target raised to $28 from $25 at Oppenheimer
The Fly

Tyra Biosciences price target raised to $28 from $25 at Oppenheimer

Oppenheimer raised the firm’s price target on Tyra Biosciences to $28 from $25 and keeps an Outperform rating on the shares following the company’s Q1 earnings results. The firm noted that it has recently noticed an uptick in investor interest in the story, which it feels “isn’t surprising as we approach initial data from SURF301 later this year.”

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App